Yi-Fei Wang (Yifei Wang)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Convolutional Neural Network

Molecular Dynamics Simulations

Respiratory Syndrome Coronavirus

Top Venues

Nature chemical biology

Science (New York, N.Y.)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yue-Shan Li, Liting Zhang, Yi-Fei Wang, Jun Zou, Ruicheng Yang, Xinling Luo, Chengyong Wu, Wei Yang, Chenyu Tian, Haixing Xu, Falu Wang, Xin Yang, Linli Li, Sheng-Yong Yang
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor. Nature communications 13 (1) (2022)
Xin Yang, Xuehui Wang, Zheng Xu, Chao Wu, Yangli Zhou, Yi-Fei Wang, Guifeng Lin, Kan Li, Ming Wu, An-Jie Xia, Jingming Liu, Lin Cheng, Jun Zou, Wei Yan, Zhenhua Shao, Sheng-Yong Yang
Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1. Nature chemical biology 18 (8) (2022)
Jingxin Qiao, Yue-Shan Li, Rui Zeng, Feng-Liang Liu, Rong-Hua Luo, Chong Huang, Yi-Fei Wang, Jie Zhang, Baoxue Quan, Chenjian Shen, Xin Mao, Xinlei Liu, Weining Sun, Wei Yang, Xincheng Ni, Kai Wang, Ling Xu, Zi-Lei Duan, Qing-Cui Zou, Hai-Lin Zhang, Wang Qu, Yang-Hao-Peng Long, Ming-Hua Li, Rui-Cheng Yang, Xiaolong Liu, Jing You, Yangli Zhou, Rui Yao, Wen-Pei Li, Jing-Ming Liu, Pei Chen, Yang Liu, Gui-Feng Lin, Xin Yang, Jun Zou, Linli Li, Yiguo Hu, Guang-Wen Lu, Wei-Min Li, Yu-Quan Wei, Yong-Tang Zheng, Jian Lei, Sheng-Yong Yang
SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model. Science (New York, N.Y.) 371 (6536) (2021)